Robotics software maker Skild AI hits $14B valuation; Orca Biosystems raises $250MM Series F from Lightspeed Venture Partners

Trending Companies

X Square Robot, a company that develops artificial general intelligence (AGI) robots based on large manipulation models, raises $140MM Series A from Bytedance.

Large Language Model (108) • Shenzhen, China

Oricell Therapeutics, a company that develops novel immunotherapies for cell therapy pipeline and proprietary discovery platform, as well as for the construction of a manufacturing plant for both clinical and commercial purposes, raises $70MM Series C from Qiming Venture Partners.

Life Sciences (1,125) • Shanghai, China

VieCure, a company that develops software platforms for oncology care, raises $43MM Equity Funding from Northpond Ventures.

Oncology (282) • Greenwood Village, CO • Post-Money Valuation

Synchrony Medical, a company that develops a respiratory therapy device designed to provide treatment for chronic obstructive pulmonary disease (COPD), recieves $1MM Grants from New Jersey Innovation Evergreen Fund.

Digital Health (477) • Jersey City, NJ • Post-Money Valuation

Inquis Medical, a company that develops a peripheral thrombectomy medical device, raises $75MM Series C from Undisclosed Investors.

Medical Devices (2,022) • Menlo Park, CA • Post-Money Valuation

Juvena Therapeutics, a company that is developing therapeutic potential of stem cell-secreted proteins and accelerating their development into life-saving therapeutics for chronic and age-related diseases, raises $33.5MM Series B from Bison Ventures.

Therapeutics (1,463) • Redwood City, CA • Post-Money Valuation

Accelsius, a manufacturer of thermal technology designed to provide a direct-to-chip liquid cooling service for artificial intelligence and other high-performance servers in data centers and edge computing locations, raises $65MM Series B from Johnson Controls.

Computer Peripherals (680) • Austin, TX • Post-Money Valuation

Cytotheryx, a preclinical cell therapy company developing cell-based treatments for liver disease, raises $60MM Series A from Ouroboros Family Founders Fund I.

Life Sciences (1,125) • Rochester, MN • Post-Money Valuation

Trailhead Biosystems, a biotechnology research company that develops high-quality human cells at scale for drug discovery and cell therapies, raises $20MM Equity Funding from MAK Capital.

Drug Research (988) • Beachwood, OH • Post-Money Valuation

EpiBiologics, a developer of protein degradation therapeutics designed to address disease-causing proteins through targeted degradation, raises $107MM Series B from GV.

Therapeutics (1,463) • San Mateo, CA • Post-Money Valuation